Kenneth Carter

Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD.

NeoDiagnostix, Inc. operates as a cancer diagnostics company. It develops molecular diagnostic and prognostic tests for the treatment of cancer. The firm offers diagnostic testing services using genetic technologies. The company was founded by Barg Upender in 2005 and is headquartered in Gaithersburg, MD.

Iterion Therapeutics, Inc. provides pharmaceuticals services. The firm products are used in the treatment of colorectal, hematopoietic, and other targeted cancers. The company was founded by Jonathan P. Northrup in 2010 and is headquartered in Houston, TX.

Noble Life Sciences, Inc. provides in vitro and in vivo preclinical drug development services. It specializes in personalized medicine and biomarker research and preclinical drug development. The company was founded by Kenneth C. Carter in 2010 and is headquartered in Sykesville, MD.

MdBio, Inc. is based in Frederick, MD. MdBio provides medical-grade, patient-tested full spectrum hemp and plant-based medicine products that are unique in the industry for their innovation, quality, and potency. Targeting ailments such as poor sleep, anxiety, pain, and weakened immune systems, their products naturally restore the body's endocannabinoid balance to maximize overall health and wellbeing in patients. Part of Maryland Technology Council, MdBio, Inc. is a company founded by four renowned medical doctors committed to providing therapeutic alternatives to pharmaceutical drugs. MdBio was acquired by Tech Council of Maryland, Inc. on February 07, 2006.

Avalon Pharmaceuticals, Inc. was a biopharmaceutical company focused on the discovery, development and commercialization of cancer therapeutics. The company was founded in November 1999 and headquartered in Germantown, MD.

Seneca Biopharma, Inc. operates as a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its pipeline includes NSI-189 small molecule program, NSI-566 stem cell therapy program, and novel & proprietary chemical entity screening platform. The company was founded by I. Richard Garr, Karl Y. Johe, and Merrill Solomon in 1996 and is headquartered in Germantown, MD.